The effect of Mobile Application on Patients who Consuming Warfarin

The effect of Educational Application based on Clinical Guideline on Medication Adherence and Readmission of Patients who Consuming Warfarin

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190730044385N1

Enrollment

144

Registered

2020-10-07

Start date

2020-10-23

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Diseases in which Warfarin is used. Condition 2: Pulmonary embolism. Condition 3: Acute embolism and thrombosis of deep veins of lower extremity. Condition 4: Atrial fibrillation and flutter. Condition 5: Vascular syndromes of brain in cerebrovascular diseases. Pulmonary embolism Acute embolism and thrombosis of deep veins of lower extremity Atrial fibrillation and flutter Vascular syndromes of brain in cerebrovascular diseases

Interventions

Intervention 1: Intervention group: : In the Intervention group, an application based on a clinical guideline on patient education that will include text, photos, and educational videos on Warfarin us

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients who have been on warfarin for at least 3 months. The patient's age is 18 to 60 years. No hearing, visual or tactile disorders. Ability to speak Persian. Have at least literacy. Have an Android smartphone. Willing to participate in the study.

Exclusion criteria

Exclusion criteria: Have Simple mobile phone. Be illiterate. Not willing to participate in the study Participants must be under 18 or over 60 years of age.

Design outcomes

Primary

Measure	Time frame
Medication adherence was used in this study to measure medication adherence using the Moriskey adherence Scale. Timepoint: Medication adherence was measured before, 30, 60, and 90 days after the intervention. Method of measurement: Medication adherence was used in this study to measure medication adherence using the Moriskey adherence Scale. The overall scores range from 0 to 8 with a score of 8, high medication adherence, a score of 6 and 7, a moderate adherence to a score. Less than 6 are considered low.;The rate of readmission is due to Warfarin side effects using a checklist. Timepoint: Readmision rate was measured before, 30, 60, and 90 days after the intervention. Method of measurement: In this study, patients' records and self-reports were used to measure readmission rates for warfarin complications, then reviewed by a researcher-made literature review checklist and then the number of readmissions recorded, And it will be calculated.	—

Measure

Time frame

Medication adherence was used in this study to measure medication adherence using the Moriskey adherence Scale. Timepoint: Medication adherence was measured before, 30, 60, and 90 days after the intervention. Method of measurement: Medication adherence was used in this study to measure medication adherence using the Moriskey adherence Scale. The overall scores range from 0 to 8 with a score of 8, high medication adherence, a score of 6 and 7, a moderate adherence to a score. Less than 6 are considered low.;The rate of readmission is due to Warfarin side effects using a checklist. Timepoint: Readmision rate was measured before, 30, 60, and 90 days after the intervention. Method of measurement: In this study, patients' records and self-reports were used to measure readmission rates for warfarin complications, then reviewed by a researcher-made literature review checklist and then the number of readmissions recorded, And it will be calculated.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Javadinejad

Tehran University of Medical Sciences

m_javadinejad@yahoo.com+98 23 3522 2193

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026